跳至主要内容
临床试验/NCT03100994
NCT03100994Unknown4 期

Post-operative Analgesia Efficacy Using Ultrasound-guided Transmuscular Quadratus Lumborum Block Versus Ultrasound-guided Quadratus Lumborum Type II Block.

Tri-Service General Hospital1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2017年3月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
180
试验地点
1
主要终点
morphine consumption

研究概览

简要总结

Post-operative analgesia efficacy using ultrasound-guided transmuscular quadratus lumborum block versus ultrasound-guided quadratus lumborum type II block

详细描述

The Quadratus Lumborum (QL) Block is an ultrasound-guided technique described by Rafael Blanco in 2007. The nerves to the lower abdominal wall can be anesthetized by injecting local anesthetics between the quadratus lumborum muscle and latissimus dorsi muscle, which is called quadratus lumborum type II block. 〝 Transmuscular quadratus lumborum block demonstrates that injectate spreads over the posterior abdominal wall to the psoas major muscle and includes the upper branches of the lumbar plexus.〞described by Adhikary in 2016. However there are no published reports comparing the 2 techniques. In our study, compared of ultrasound-guided QL2-blocks with transmuscular quadratus lumborum block to investigate analgesic consumption, pain level, opioid related side effects and mobilization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists classification (ASA) 1~3
  • adequate communication skills
  • Body mass index < 32

排除标准

  • chronic pain neurological illness/ neuropathy contraindication against local anesthetics

研究组 & 干预措施

Group B

Active Comparator

Ultrasound guided transmuscular quadratus lumborum block with 0.125% bupivacaine 30ml

干预措施: Bupivacaine (Drug)

Group B

Active Comparator

Ultrasound guided transmuscular quadratus lumborum block with 0.125% bupivacaine 30ml

干预措施: Ultrasound (Device)

Group C

Active Comparator

Ultrasound guided quadratus lumborum type 2 block with 0.125% bupivacaine 30ml

干预措施: Bupivacaine (Drug)

Group C

Active Comparator

Ultrasound guided quadratus lumborum type 2 block with 0.125% bupivacaine 30ml

干预措施: Ultrasound (Device)

结局指标

主要结局

morphine consumption

时间窗: 48 hours

morphine consumption

次要结局

  • Nausea or vomiting(48 hours)
  • Skin itch(48 hours)
  • Severity of postoperative pain via visual analogue pain scale (VAS)(48 hours)
  • time to mobilization(48 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wu Hsuan-Cheng

Principal Investigator, Department of Anesthesiology,Tri-ServiceGeneralHospital

Tri-Service General Hospital

研究点 (1)

Loading locations...

相似试验